VRNA - Verona Pharma plc Company Cash Volume

Public company logo of veronapharma.com (VRNA)

Verona Pharma plc (VRNA) possesses high growth potential driven by low-cost mass production of inhalers following the completion of trials. David Zaccardi's management team is currently focusing on the execution of the commercial sales plan. However, geopolitical risks and raw material import complexities create certain barriers. The cash position helps assess the business's financial autonomy, while 0.44 records a new level mark.

Verona Pharma Corp - VRNA Company Cash Balance (period 07/04/2022 - 10/18/2025)

Financial and market metric breakdowns for Verona Pharma (VRNA)

- stock value and consensus price forecast:
Comprehensive company analysis:VRNA Verona Pharma plc
Brand item of veronapharma.com

Verona Pharma plc (VRNA) respiratory drug development is independent of economic cycles, ensuring a stable cash flow. The trend in cash reserves reflects the company's current financial flexibility while awaiting regulatory approval. This indicator captures daily changes in liquid assets, where sharp spikes may signal either capital inflows or asset sales. A high cash balance confirms the business's resilience to macro shocks.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Jyong Biotech - Company Cash on Hand|LGND: Company Cash and Cash Equivalents|AMRX: Company Cash on Hand|Company Cash Reserve Perrigo Company plc|ALVO: Company Cash Volume|Liquidia (LQDA) - Company Cash Volume|Company Cash Funds Galapagos N.V.|Company Cash on Hand ANI Pharmaceuticals, Inc. (ANIP)|Company Cash Volume MNKD|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance